【摘要】目的调查研究血液透析患者血清25-羟维生素D[25 hydroxyvitamin D,25(OH)D]水平与其心血管功能的关系。方法采用横断面调查研究方法，收集战略支援部队特色医学中心血液净化中心109名血液透析患者血清标本测定血清25(OH)D水平、临床指标及心脏彩超结果，应用相关分析及多元回归分析血清25(OH)D水平与心脏功能相关性。结果患者血清25(OH)D平均值为(50.39± 22.74) nmol/L，其中低血清25(OH)D 者(≤50 nmol/L)共有65 人，占59.6%。正常25(OH)D 患者与低25(OH)D 患者比较，二尖瓣口E 峰与二尖瓣环E 峰血流速度比值(e/e’)有明显差异(t=2.425,P=0.001)。Spearman 分析显示25(OH)D 与e/e´呈负相关(r=- 0.272,P=0.004)。多元回归分析显示25(OH)D 为e/e´的独立相关因素(β =-0.115,95%CI:-0.129～-0.009，P=0.010)。结论维持性血液透析患者普遍血清25(OH)D 水平偏低，血清25(OH)D水平与左心室舒张功能独立相关。
【Abstract】Objective To investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) level and cardiovascular function in hemodialysis patients. Methods This was a cross-sectional study. Serum 25(OH)D levels were determined from 109 hemodialysis patients treated in the Dialysis Center of the PLA Strategic Support Force Medical Center. Clinical data and cardiac ultrasound results of the 109 hemodialysis patients were collected. Correlation and multivariate regression analyses were used to evaluate the relationship between serum 25(OH)D level and cardiovascular function. Results The average value of 25(OH)D was
50.39±22.74 nmol/L in the hemodialysis patients, in which 65 patients (59.6%) were identified as 25(OH)D deficient (≤50nmol/L). By comparing between 25(OH)D normal group and 25(OH)D deficient group, there were no significant differences in B-type natriuretic peptide (BNP), high- sensitivity C-reactive protein (hs-CRP), intact parathyroid hormone (iPTH), hemoglobin, left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), fraction shortening (FS), left ventricular internal dimensions at end-diastole (LVIDd), posterior wall thickness at end- diastole (PWTd), septal wall thickness at end- diastole (SWTd), left ventricular end diastolic diameter (LVED), systolic left ventricular volume (LVES) and the ratio of mitralwave E peak velocity to A peak velocity (e/a), but there was a significant difference in the ratio mitral-wave E peak velocity to mitral annulus velocity E’(e/e ́) (t=2.495, P=0.001). Spearman analysis showed that 25(OH) D was negatively correlated with e/e ́ (r=-0.272, P=0.004). Multivariate regression showed that 25(OH)D was an independent correlation factor for e/e´(β=-0.115, 95% CI: -0.129～-0.009, P=0.010). Conclusions Serum 25(OH)D level was lower in maintenance hemodialysis patients. 25(OH)D level was independently and negatively correlated with left ventricular diastolic function.
[1] Holick MF. Vitamin D deficiency[J]. N Engl J Med, 2007, 357(3):266-281.
[2] Pilz S, Verheyen N, Grubler MR, Tomaschitz A, Marz W. Vitamin D and cardiovascular disease prevention[J]. Nat Rev Cardiol, 2016, 13(7):404-417.
[3] Orkaby AR, Djousse L, Manson JE. Vitamin D supplements and prevention of cardiovascular disease[J]. Curr Opin Cardiol, 2019, 34(6):700-705.
[4] Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients[J]. Kidney Int, 2007, 72(8):1004-1013.
[5] Rouached M, El Kadiri Boutchich S, Al Rifai AM, Garabedian M, Fournier A. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease[J]. Kidney Int, 2008, 74(3):389-390.
[6] Drechsler C, Pilz S, Obermayer-Pietsch B, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients[J]. Eur Heart J, 2010, 31(18):2253-2261.
[7] Kruit A, Zanen P. The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases[J]. Clin Biochem, 2016, 49(7-8):534-537.
[8] Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review[J]. Nat Rev Cardiol, 2009, 6(10):621-630.
[9] Wimalawansa SJ. Vitamin D and cardiovascular diseases: Causality[J]. J Steroid Biochem Mol Biol, 2018, 175:29-43.
[10] Kiani A, Mohamadi-Nori E, Vaisi-Raygani A, et al. Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases[J]. Molecular biology reports, 2019, 46(5):5225-5236.
[11] Costabel JP, Galve E, Terricabras M, et al. E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy[J]. Echocardiography, 2018, 35(7):935-940.
[12] Weber KT, Simpson RU, Carbone LD. Vitamin D and calcium dyshomoeostasis-associated heart failure[J]. Heart, 2008, 94(5):540-541.
[13] Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?[J]. Kidney Int, 2005, 68(5):1973-1981.
[14] Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice[J]. Endocr Rev, 2008, 29(6):726-776.
[15] Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects[J]. Physiol Rev, 2016, 96(1):365-408.
[16] 史云聪，王立立，郭艺芳. 维生素D与心血管疾病相关性研究进展[J]. 心血管病学进展, 2020, 41(8):826-829.
